NASDAQ:NBSE
Delisted

Neubase Therapeutics Stock News

etoro logo Buy NBSE
*Your capital is at risk
$0.378
+0 (+0%)
At Close: Aug 09, 2024
PITTSBURGH, April 26, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE), (“NeuBase”), a biotechnology company accelerating the genetic revolution with a new class of precision gen
PITTSBURGH, April 22, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase”), a biotechnology company accelerating the genetic revolution with a new class of precision gene
PITTSBURGH, April 21, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase”), a biotechnology company accelerating the genetic revolution with a new class of precision gene
One of its investors praised the company in a quarterly performance update.
David Einhorn (Trades, Portfolio)'s hedge fund, Greenlight Capital, ended 2020 on a high note. After a rough start to the year, Greenlight added 25% in the fourth quarter of 2020, making it the best q
Registration For This FREE Tribe Public Presentation and Q&A Event Is Now Open at NeuBase22.TribePublic.com SAN FRANCISCO, CA / ACCESSWIRE / December 18, 2020 / Tribe Public announced today that Dietr
THE launch of a new local airline has been delayed again. The soft launch of SKS Airways Sdn Bhd was originally set to take place at Pangkor Airport this Tuesday (Sept 15), with several senior governm
David Einhorn's 13F stock portfolio value increased from $702M to $922M this quarter. Greenlight added Vaneck Gold Miners ETF and Atlas Air Worldwide while dropping Altice USA and Adient plc.
Strong Pharmacokinetic and Pharmacodynamic Data Presented in March Validate Platform and Position Company for Scalable Output of Synthetic Precision Genetic Medicines Company Continues to Progress Ca
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
Individual investors are placing their bets on biotech companies pursuing coronavirus advances. Some invest for fun and profit, while others want to be a part of a historic breakthrough.
Novovax shares have climbed nearly 4,000% so far this year on excitement over the company’s Covid-19 vaccine.
MRNA, PFE/BNTX, and AZN are leading the three vaccines in clinical phase 3 trials. Vaccines developed using different vectors have different advantages and disadvantages.

7 Growth Stocks to Ride for the Rest of 2020

07:20pm, Tuesday, 04'th Aug 2020
Investors can count on these growth stocks to deliver consistent, positive returns for the remainder of this year and beyond.
Moderna (MRNA) stock just pulled back to a long-term bullish trendline on the charts , and has cheap options to boot
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE